Employees: 718
Size Nanjing Well Pharmaceutical (603351.SS) is a China Materials company (Chemicals: Major Diversified) with a market value of $550M, the 3462nd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥26.96 on 18 Nov 2026.
Performance Over six months the shares fell 2.1%, against -19.1% for the median peer and -20.0% for the China market (cap-weighted) — 3rd highest of 20 in its peer set.
Growth Revenue grew 6.5% over the last twelve months (peer median +7.9%); the operating margin is 13.1% (peer median 7.2%).
Valuation It trades at 2.7× enterprise value to sales against a peer median of 2.9× (11th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about 3% a year for seven years (Req g). Recent delivered growth is +13%, so the hurdle is -10 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 3.5 points above its cost of capital (7.1% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.40B | CN¥1.33B | CN¥1.29B | CN¥1.15B | CN¥1.11B |
| Revenue growth | — | +3% | +12% | +4% | — |
| Gross profit | CN¥470M | CN¥349M | CN¥332M | CN¥290M | CN¥280M |
| EBITDA | n/a | CN¥309M | CN¥285M | CN¥205M | CN¥190M |
| Net income | CN¥157M | CN¥151M | CN¥146M | CN¥112M | CN¥95.0M |
| Free cash flow | CN¥208M | CN¥186M | CN¥171M | CN¥47.2M | -CN¥124M |
| Capital expenditure | CN¥67.1M | CN¥52.2M | CN¥51.5M | CN¥73.1M | CN¥234M |
| Total debt | CN¥331M | CN¥575M | CN¥481M | CN¥499M | CN¥454M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 603351.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +0.4% | -11.1% | 4th highest of 21 |
| 6-month return | -2.1% | -19.1% | 3rd highest of 20 |
| Distance from 52-week high | -12.5% | -41.4% | 2nd highest of 21 |
| Revenue growth (TTM) | +6.5% | +7.9% | 10th lowest of 21 |
| Operating margin | 13.1% | 7.2% | 7th highest of 21 |
| EV / Sales | 2.7× | 2.9× | 11th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | 3.0% | 11.7% | 4th least demanding of 13 |
| Growth delivered (Del g) | +12.7% | +11.2% | 6th highest of 13 |
| Hurdle (Req g minus delivered) | -9.7 pp | +4.6 pp | 4th least demanding of 13 |
| ROIC minus cost of capital | +3.5 pp | +0.2 pp | 5th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Nanjing Well Pharmaceutical 603351.SS | China | $550M | -2% | +7% | 13% | 2.7× | 3.0% | +12.7% |
| Ningbo Bohui Chemical Technology 300839.SZ | China | $533M | -35% | +42% | 4% | 1.0× | 1.2% | +23.1% |
| Jiangsu Kuangshun Photosensitivity New Material Stock 300537.SZ | China | $568M | -33% | +15% | 6% | 6.5× | 41.7% | -8.5% |
| China Catalyst 688267.SS | China | $532M | -38% | -3% | 18% | 3.4× | n/a | n/a |
| Polyrocks Chemical 688669.SS | China | $529M | -16% | -8% | -6% | 1.6× | 27.6% | +15.2% |
| Hubei Kailong Chemical 002783.SZ | China | $528M | -18% | -2% | 8% | 1.8× | -2.9% | +12.0% |
| Archean Chemical Industries ACI.NS | India | $576M | -19% | +6% | 12% | 5.0× | n/a | n/a |
| Shandong Taihe Technologies 300801.SZ | China | $582M | -42% | -2% | 7% | 1.2× | 5.2% | +12.9% |
| Zhejiang Dragon Technology 603004.SS | China | $582M | -22% | -11% | 16% | 4.2× | 15.8% | +1.7% |
| Hunan Xiangtou Goldsky Titanium Industry Technology 688750.SS | China | $585M | -29% | +4% | 6% | 6.2× | 28.9% | -4.3% |
| Beijing WBD New Materials 300055.SZ | China | $512M | -56% | +13% | -9% | 1.7× | n/a | n/a |
| Shandong Jianbang New Material 603285.SS | China | $594M | -50% | +8% | 22% | 4.8× | n/a | n/a |
| Soken Chemical & Engineering 4972.T | Japan | $507M | +54% | +11% | 14% | 1.3× | -1.2% | +8.8% |
| Ningxia Zhongke Biotechnology 600165.SS | China | $601M | -17% | +8% | -73% | 7.7× | n/a | n/a |
| Prasol Chemicals PRASOLCHEM.NS | India | $496M | n/a | +22% | 10% | 3.8× | 24.8% | +15.8% |
| China Steel Chemical 1723.TW | Taiwan | $484M | -11% | +8% | 12% | 2.5× | 3.7% | +1.6% |
| Shandong Rike Chemical 300214.SZ | China | $483M | -9% | -6% | 2% | 1.3× | 7.5% | +10.5% |
| Anhui Huaertai Chemical 001217.SZ | China | $482M | -16% | +13% | -3% | 1.6× | n/a | n/a |
| Foseco India FOSECOIND.NS | India | $476M | +21% | +47% | 18% | 5.1× | 27.8% | +20.7% |
| China Sunsine Chemical QES.SI | Singapore | $474M | -9% | +4% | 14% | 0.3× | n/a | n/a |
| Shandong Sanyuan Biotechnology 301206.SZ | China | $644M | -21% | +15% | 4% | 3.7× | n/a | n/a |